
    
      The drugs dexamethasone and bortezomib are both FDA-approved drugs for the treatment of
      multiple myeloma, a disease very similar to amyloidosis. However, they are currently
      investigational for the treatment of amyloidosis.

      The investigators want to find out if the addition of dexamethasone and bortezomib to
      standard treatment of high dose chemotherapy and stem cell transplant can help improve
      response to treatment.
    
  